Coldstream Capital Management’s Insmed INSM Stock Holding History

Coldstream Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$433K	Buy	4,057 +320	+9%	+$38.7K	0.01%	806
2026 Q1	$611K	Sell	3,737 -111	-3%	-$17.1K	0.01%	646
2025 Q4	$670K	Sell	3,848 -672	-15%	-$123K	0.01%	594
2025 Q3	$651K	Sell	4,520 -455	-9%	-$55.7K	0.01%	624
2025 Q2	$501K	Buy	4,975 +244	+5%	+$18.7K	0.01%	654
2025 Q1	$361K	Buy	4,731 +1,180	+33%	+$90.3K	0.01%	749
2024 Q4	$245K	Buy	3,551 +61	+2%	+$4.39K	0.01%	927
2024 Q3	$255K	Buy	+3,490	New	+$258K	0.01%	922

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Coldstream Capital Management's INSM Position: Q2 2026 in Review

Coldstream Capital Management increased its Insmed (INSM) stake by 8.6% in Q2 2026, buying an estimated $38.7K and bringing the position to 4,057 shares worth $433K. The position accounts for 0.01% of the portfolio, ranked #806.

Coldstream Capital Management first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $670K in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Coldstream Capital Management held 4,057 shares of Insmed worth $433K as of Q2 2026.
Coldstream Capital Management bought 320 Insmed shares in Q2 2026, an estimated $38.7K.
Insmed made up 0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #806 holding.
Coldstream Capital Management first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
Coldstream Capital Management's Insmed position peaked at $670K in Q4 2025.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.